title

Exchanges at Goldman Sachs

Goldman Sachs

131
Followers
457
Plays
Exchanges at Goldman Sachs

Exchanges at Goldman Sachs

Goldman Sachs

131
Followers
457
Plays
OVERVIEWEPISODESYOU MAY ALSO LIKE

Details

About Us

In each episode of "Exchanges at Goldman Sachs," people from the firm share their insights on developments shaping industries, markets and the global economy.

Latest Episodes

Client Call: Market Volatility and Potential Economic Impacts

In an effort to provide timely and valuable updates regarding ongoing market volatility and potential economic impacts, we’re sharing a “Market Update” call hosted by our Investment Banking Division. In the conversation, Goldman Sachs President and COO John Waldron provides an update on the current environment, alongside other senior leaders across the firm.

54 MIN17 h ago
Comments
Client Call: Market Volatility and Potential Economic Impacts

Markets Update: Europe and COVID-19

Andrew Wilson of Goldman Sachs Asset Management explains how volatility in U.S. financial markets from the COVID-19 outbreak is playing out across Europe as well. “European markets have been very much in the eye of the storm,” Wilson says. “So the focus is on what policy responses are coming out of Europe, just as much as it is out of the U.S.”

10 MIN6 d ago
Comments
Markets Update: Europe and COVID-19

Update on US Growth and Earnings Forecasts, and Expected Stimulus Programs

Goldman Sachs’ top economists and strategists discuss revised forecasts for the US economy and corporate earnings and the prospect of federal stimulus programs in the face of the COVID-19 outbreak.

38 MIN1 w ago
Comments
Update on US Growth and Earnings Forecasts, and Expected Stimulus Programs

Markets Update: How COVID-19 Is and Isn't Like the '08 Financial Crisis

Joe Montesano, head of Americas Equity Trading for Goldman Sachs, analyzes how the coronavirus pandemic continues to add volatility to markets. Montesano also talks about parallels and differences in today's market environment compared to that of the 2008 global financial crisis.

14 MIN1 w ago
Comments
Markets Update: How COVID-19 Is and Isn't Like the '08 Financial Crisis

Re-thinking How We Work During a Pandemic

Amid the uncertainty surrounding the coronavirus pandemic, Goldman Sachs’ global medical director Dr. Michael Rendel joins by phone to talk about what employees can do to stay healthy and productive while working remotely – from setting up comfortable work stations to taking time for meditation and exercise. Dr. Rendel also talks about the importance of managers supporting their teams’ physical and psychological well-being, as well as the firm’s strategy more broadly in terms of coordinating global offices.

26 MIN2 w ago
Comments
Re-thinking How We Work During a Pandemic

Markets Update: The Fed's Recent Efforts to Increase Liquidity

Alex Blanchard of Goldman Sachs' Global Markets Division analyzes the Fed's recent decisions to increase liquidity amidst market volatility.

16 MIN2 w ago
Comments
Markets Update: The Fed's Recent Efforts to Increase Liquidity

After a Sharp Drop in Prices, What's Next for Oil?

Jeff Currie, global head of Commodities Research for Goldman Sachs, explains the latest on the price war in the oil market.

14 MIN3 w ago
Comments
After a Sharp Drop in Prices, What's Next for Oil?

Markets Update: March 6, 2020

Amelia Garnett of Goldman Sachs' Global Markets Division provides a quick update on how investors are responding to ongoing volatility around coronavirus concerns.

7 MIN3 w ago
Comments
Markets Update: March 6, 2020

How Computational Biology is Transforming Drug R&D

The latest episode of Exchanges at Goldman Sachs premieres a new monthly feature: An examination of a topic at the center of conversations in the venture-capital community. This week,Goldman Sachs Research’s Heath Terry explores the growing world of computational biology—using the power of big data to revolutionize drug discovery, disease prevention and cancer detection. Terry talked to VCs like Lux Capital’s Zavain Dar, who invests in emerging science and technology firms. “It feels like we’re at the precipice of what I think will be a multi-decade revolution in how biology and chemistry are fundamentally practiced,” explains Dar. Terry also spoke with James Field, CEO of computational-biology startup LabGenius, which is using machine learning to more easily identify useful proteins for the human body. “If we can deploy technology in building out some discovery platforms in a way that the learnings compound over time,” says Field, “then it will dramatically change the economics of discovering and developing drug molecules.”

10 MINMAR 3
Comments
How Computational Biology is Transforming Drug R&D

Markets Update: Coronavirus

After a volatile week in markets, Erin Riley of Goldman Sachs’ Consumer and Investment Management Division talks about how coronavirus is weighing on investor sentiment.

13 MINFEB 28
Comments
Markets Update: Coronavirus

Latest Episodes

Client Call: Market Volatility and Potential Economic Impacts

In an effort to provide timely and valuable updates regarding ongoing market volatility and potential economic impacts, we’re sharing a “Market Update” call hosted by our Investment Banking Division. In the conversation, Goldman Sachs President and COO John Waldron provides an update on the current environment, alongside other senior leaders across the firm.

54 MIN17 h ago
Comments
Client Call: Market Volatility and Potential Economic Impacts

Markets Update: Europe and COVID-19

Andrew Wilson of Goldman Sachs Asset Management explains how volatility in U.S. financial markets from the COVID-19 outbreak is playing out across Europe as well. “European markets have been very much in the eye of the storm,” Wilson says. “So the focus is on what policy responses are coming out of Europe, just as much as it is out of the U.S.”

10 MIN6 d ago
Comments
Markets Update: Europe and COVID-19

Update on US Growth and Earnings Forecasts, and Expected Stimulus Programs

Goldman Sachs’ top economists and strategists discuss revised forecasts for the US economy and corporate earnings and the prospect of federal stimulus programs in the face of the COVID-19 outbreak.

38 MIN1 w ago
Comments
Update on US Growth and Earnings Forecasts, and Expected Stimulus Programs

Markets Update: How COVID-19 Is and Isn't Like the '08 Financial Crisis

Joe Montesano, head of Americas Equity Trading for Goldman Sachs, analyzes how the coronavirus pandemic continues to add volatility to markets. Montesano also talks about parallels and differences in today's market environment compared to that of the 2008 global financial crisis.

14 MIN1 w ago
Comments
Markets Update: How COVID-19 Is and Isn't Like the '08 Financial Crisis

Re-thinking How We Work During a Pandemic

Amid the uncertainty surrounding the coronavirus pandemic, Goldman Sachs’ global medical director Dr. Michael Rendel joins by phone to talk about what employees can do to stay healthy and productive while working remotely – from setting up comfortable work stations to taking time for meditation and exercise. Dr. Rendel also talks about the importance of managers supporting their teams’ physical and psychological well-being, as well as the firm’s strategy more broadly in terms of coordinating global offices.

26 MIN2 w ago
Comments
Re-thinking How We Work During a Pandemic

Markets Update: The Fed's Recent Efforts to Increase Liquidity

Alex Blanchard of Goldman Sachs' Global Markets Division analyzes the Fed's recent decisions to increase liquidity amidst market volatility.

16 MIN2 w ago
Comments
Markets Update: The Fed's Recent Efforts to Increase Liquidity

After a Sharp Drop in Prices, What's Next for Oil?

Jeff Currie, global head of Commodities Research for Goldman Sachs, explains the latest on the price war in the oil market.

14 MIN3 w ago
Comments
After a Sharp Drop in Prices, What's Next for Oil?

Markets Update: March 6, 2020

Amelia Garnett of Goldman Sachs' Global Markets Division provides a quick update on how investors are responding to ongoing volatility around coronavirus concerns.

7 MIN3 w ago
Comments
Markets Update: March 6, 2020

How Computational Biology is Transforming Drug R&D

The latest episode of Exchanges at Goldman Sachs premieres a new monthly feature: An examination of a topic at the center of conversations in the venture-capital community. This week,Goldman Sachs Research’s Heath Terry explores the growing world of computational biology—using the power of big data to revolutionize drug discovery, disease prevention and cancer detection. Terry talked to VCs like Lux Capital’s Zavain Dar, who invests in emerging science and technology firms. “It feels like we’re at the precipice of what I think will be a multi-decade revolution in how biology and chemistry are fundamentally practiced,” explains Dar. Terry also spoke with James Field, CEO of computational-biology startup LabGenius, which is using machine learning to more easily identify useful proteins for the human body. “If we can deploy technology in building out some discovery platforms in a way that the learnings compound over time,” says Field, “then it will dramatically change the economics of discovering and developing drug molecules.”

10 MINMAR 3
Comments
How Computational Biology is Transforming Drug R&D

Markets Update: Coronavirus

After a volatile week in markets, Erin Riley of Goldman Sachs’ Consumer and Investment Management Division talks about how coronavirus is weighing on investor sentiment.

13 MINFEB 28
Comments
Markets Update: Coronavirus

More from Goldman Sachs

Show

Playlists

Coronavirus Updates
Team Himalaya
XX+
fuller.julia
days XII - XIV
fuller.julia
day ix, day x, day xi
fuller.julia
hmly
Welcome to Himalaya Premium